Study of Sagittal Pelvic Statics in the Sitting Position in Children With Cerebral Palsy (SPS-PC)

September 24, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Cerebral palsy is the leading cause of motor disability in children. Children with little or no walking (GMFCS III, IV and V) represent 43% of children with cerebral palsy, the majority of whom present pelvic and spinal deformities in the frontal and sagittal planes. However, sagittal pelvic spinal statics have been little studied, especially in the sitting position, which is the functional position of these children.

Moreover, there are currently no recommendations on how to perform follow-up radiographs of the spine in children who do not walk much.

A better understanding of pelvic and sagittal spinal statics would help prevent deformities and their complications.

Standardizing the method of performing pelvic-spinal radiographs in the sitting position will make monitoring of spinal statics more reliable.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 17 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Children and adolescents from 4 to 17 years old with cerebral palsy GMFCS III, IV or V followed in the Physical Medicine and Rehabilitation Department, Children Rehabilitation Unit of the CHU of Nîmes

Description

Inclusion Criteria:

  • Child or adolescent aged 4 to 17 years
  • Child or adolescent with cerebral palsy GMFCS III, IV or V
  • Child or adolescent whose parents, or the child if possible, have given free, informed and written consent
  • Child or adolescent affiliated or beneficiary of a health insurance plan

Exclusion Criteria:

  • Child or adolescent with history of spinal surgery
  • Child or adolescent with parents unable to give consent
  • Child or adolescent participating in a therapeutic research study (RIPH 1 or drug study)
  • Child or adolescent in an exclusion period determined by another study
  • Child or adolescent under court protection, guardianship or curatorship
  • Pregnant, parturient or breastfeeding patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Child with Cerebral Palsy
Children and adolescents from 4 to 17 years old with cerebral palsy GMFCS III, IV or V followed in the Physical Medicine and Rehabilitation Department, Children's Rehabilitation Unit of the University Hospital of Nîmes (Carémeau Hospital)
X-ray of the spine and pelvis from the front and the side will be performed under the standardized conditions that we put in place: in a sitting position on a specific modular chair.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution of the sagittal spinal statics in the sitting position
Time Frame: At baseline
pelvic version (angle between the vertical and the line joining the center of the femoral heads with the middle of the sacral plateau (in degrees))
At baseline
Evolution of the sagittal spinal statics in the sitting position
Time Frame: At baseline
lordoses cervicales (in degrees)
At baseline
Evolution of the sagittal spinal statics in the sitting position
Time Frame: At baseline
lumbar lordosis (in degrees)
At baseline
Evolution of the sagittal spinal statics in the sitting position
Time Frame: At baseline
thoracic kyphosis (in degrees)
At baseline
Evolution of the sagittal spinal statics in the sitting position
Time Frame: At baseline
measurement of pelvic incidence (normal values between 35 and 85 degrees)
At baseline
Evolution of the sagittal spinal statics in the sitting position
Time Frame: At baseline
sacral slope (angle of inclination of the sacral plateau in profile to the horizontal (degrees))
At baseline
Evolution of the sagittal spinal statics in the sitting position
Time Frame: At baseline
Cobb angle (if scoliosis) (curvature greater than 10 degrees : definition of scoliosis; between 10 and 15 degree: benign scoliosis; between 15 and 35 degrees: moderate scoliosis; curvature greater than 35 degrees: significant scoliosis.)
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Anissa MEGZARI, Centre Hospitalier Universitaire de Nīmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2023

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

December 12, 2022

First Submitted That Met QC Criteria

December 12, 2022

First Posted (Actual)

December 20, 2022

Study Record Updates

Last Update Posted (Estimated)

September 29, 2025

Last Update Submitted That Met QC Criteria

September 24, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Local/2022/CL-01
  • ANSM (Other Identifier: 2025-A01697-42)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy Infantile

Clinical Trials on spine and pelvis radiography

Subscribe